Supplementary Table 1: HPV type-specific longitudinal prevalence HIV negative HIV positive Visit 1 Visit 2 Visit 1 Visit 2 HPV Prevalence HPV Prevalence HPV Prevalence HPV Prevalence n/N (%) n/N (%) n/N (%) n/N (%) High-risk HPV types HPV-16 1/72 (1.4) 3/38 (7.9) 10/93 (10.8) 5/47 (10.6) HPV-18 0/72 (0) 1/38 (2.6) 6/93 (6.5) 2/47 (4.3) HPV-26 0/72 (0) 0/38 (0) 0/93 (0) 0/47 (0) HPV-31 0/72 (0) 0/38 (0) 4/93 (4.3) 1/47 (2.1) HPV-33 1/72(1.4) 0/38 (0) 1/93 (1.1) 1/47 (2.1) HPV-35 1/72 (1.4) 2/38 (5.3) 6/93 (6.5) 2/47 (4.3) HPV-39 1/72 (1.4) 2/38 (5.3) 5/93 (5.4) 3/47 (6.4) 3/72 (4.2) 1/38 (2.6) 8/93 (8.6) 7/47 (14.9) HPV-45 HPV-51 0/72 (0) 0/38 (0) 4/93 (4.3) 2/47 (4.3) HPV-52 2/72 (2.8) 0/38 (0) 11/93 (11.8) 9/47 (19.1) HPV-53 1/72 (1.4) 1/38 (2.6) 5/93 (5.4) 4/47 (8.5)
Supplementary Table 1: HPV type-specific longitudinal prevalence HIV negative HIV positive Visit 1 HPV Prevalence n/N (%) Visit 2 HPV Prevalence n/N (%) Visit 1 HPV Prevalence n/N (%) Visit 2 HPV Prevalence n/N (%) High-risk HPV types HPV-16 1/72 (1.4) 3/38 (7.9) 10/93 (10.8) 5/47 (10.6) HPV-18 0/72 (0) 1/38 (2.6) 6/93 (6.5) 2/47 (4.3) HPV-26 0/72 (0) 0/38 (0) 0/93 (0) 0/47 (0) HPV-31 0/72 (0) 0/38 (0) 4/93 (4.3) 1/47 (2.1) HPV-33 1/72(1.4) 0/38 (0) 1/93 (1.1) 1/47 (2.1) HPV-35 1/72 (1.4) 2/38 (5.3) 6/93 (6.5) 2/47 (4.3) HPV-39 1/72 (1.4) 2/38 (5.3) 5/93 (5.4) 3/47 (6.4) HPV-45 3/72 (4.2) 1/38 (2.6) 8/93 (8.6) 7/47 (14.9) HPV-51 0/72 (0) 0/38 (0) 4/93 (4.3) 2/47 (4.3) HPV-52 2/72 (2.8) 0/38 (0) 11/93 (11.8) 9/47 (19.1) HPV-53 1/72 (1.4) 1/38 (2.6) 5/93 (5.4) 4/47 (8.5)
1-s2.0-S0042682216300526-mmc1.docx